Skip to main content

Inpatient Rehab Program Aids Adaptation to Epilepsy Diagnosis

Medically reviewed by Carmen Pope, BPharm. Last updated on April 19, 2024.

By Lori Solomon HealthDay Reporter

FRIDAY, April 19, 2024 -- An inpatient, epilepsy-related rehabilitation program shows lasting effects on several aspects of adaptation to epilepsy and quality of life, according to a study published April 16 in Epilepsia.

Ulrich Specht, from the Medical School OWL at Bielefeld University in Germany, and colleagues evaluated the efficacy of a specialized inpatient rehabilitation program in patients with newly diagnosed epilepsy. The analysis included one-year outcomes among 74 patients with newly diagnosed epilepsy after completing the inpatient rehabilitation program versus 56 patients with similar epilepsy duration, but without rehabilitation in the first year after diagnosis.

The researchers found that at follow-up, the rehabilitation group was favored for emotional adaptation to epilepsy, overall quality of life, overall health, perceived restrictions because of epilepsy, and subjective level of information about epilepsy. For depression and anxiety or employment status, there were no significant differences observed between the groups. Additionally, at one-year follow-up, patients in the rehabilitation group were more often seizure-free and less often on sickness absence than control patients.

"Since reduced quality of life shortly after diagnosis of newly diagnosed epilepsy is associated with seizure recurrence, an early identification of patients with a greater need for support seems important," the authors write.

Abstract/Full Text

Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

© 2024 HealthDay. All rights reserved.

Read this next

ACG: 2000 to 2022 Saw Rise in Early-Onset CRC Mortality in the United States

THURSDAY, Oct. 31, 2024 -- Early-onset colorectal cancer (EO-CRC) mortality rose in the United States over the past two decades, most notably in patients aged 20 to 44 years...

Cell-Free Blood DNA Tests Less Effective Than Other CRC Screening

WEDNESDAY, Oct. 30, 2024 -- Cell-free DNA blood tests (cf-bDNA) may be more costly and less effective for colorectal cancer (CRC) screening than other screening modalities...

American College of Surgeons, Oct. 19-22

The annual meeting of the American College of Surgeons was held this year from Oct. 19 to 22 in San Francisco and attracted participants from around the world, including...

More news resources

Subscribe to our newsletter

Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.